A Study on Peichori Kudineer(Internal) and Sainthavaathi Lebanam(External) for the treatment of SEETHAPITHAM (URTICARIA) in the Paediatric age group.

A Preclinical and double-arm clinical Study to evaluate the Therapeutic efficacy of PEICHORI KUDINEER (Internal) and SAINTHAVAATHI LEBANAM (External) in the Management of SEETHA PITHAM(URTICARIA) in the Paediatric age group. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104110

Enrollment

Registered

2026-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria Health Condition 2: L508- Other urticaria Health Condition 3: L509- Urticaria, unspecified

Interventions

Intervention1: PEICHORI KUDINEER (Internal): Should Be Administered Orally Twice a day After Food Dosage (According to age group and body weight)3-12 years- 15-30ml. Duration 7 days. Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: Urticaria symptoms like wheals,redness,pruritus, Allergic reactions which includes Foods,vegetable spices,and fruits Medications plants Food preservatives Industrial materials physical stimuli Insect bite/stings

Exclusion criteria

Exclusion criteria: Children below 2 years and above 12 years Auto immune cause Mastocytosis Stills disease Atopic dermatitis Infection induced urticaria Erythema multiforme

Design outcomes

Primary

Measure	Time frame
The study is expected to prove the safety and efficacy of Peichori Kudineer and Sainthavaathi Lebanam in children with Seethapitham, showing relief in itching, redness, wheals, reduced recurrence, and evidence-based Siddha validation.Timepoint: The Study Outcomes Including Symptomatic Relief (Reduction in itching,wheals,erythema)Reduction in recurrence and Improvement in quality of life,Will be asessed at predefined time intervals-At Baseline(Day0),During Treatment(Day3) and at the end of Treatment (1 Week)-to evaluate the safety and Therapeutic efficacy of PeichoriKudineer(Internal)and Sainthavaathi Lebanam(External)in the management of Seethapitham (Urticaria) in the Paediatric age group.	—

Measure

Time frame

The study is expected to prove the safety and efficacy of Peichori Kudineer and Sainthavaathi Lebanam in children with Seethapitham, showing relief in itching, redness, wheals, reduced recurrence, and evidence-based Siddha validation.Timepoint: The Study Outcomes Including Symptomatic Relief (Reduction in itching,wheals,erythema)Reduction in recurrence and Improvement in quality of life,Will be asessed at predefined time intervals-At Baseline(Day0),During Treatment(Day3) and at the end of Treatment (1 Week)-to evaluate the safety and Therapeutic efficacy of PeichoriKudineer(Internal)and Sainthavaathi Lebanam(External)in the management of Seethapitham (Urticaria) in the Paediatric age group.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr A ANBUMALAR MD S

Government Siddha Medical College and Hospital,Palayamkottai

anbumalara@gmail.com9788232433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026